These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16272183)

  • 1. Gender differences in response to lorazepam in a human drug discrimination study.
    Jackson A; Stephens D; Duka T
    J Psychopharmacol; 2005 Nov; 19(6):614-9. PubMed ID: 16272183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low dose alcohol drug discrimination in social drinkers: relationship with subjective effects.
    Jackson A; Stephens DN; Duka T
    Psychopharmacology (Berl); 2001 Oct; 157(4):411-20. PubMed ID: 11605101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam.
    Lister RG; File SE
    J Clin Psychopharmacol; 1983 Apr; 3(2):66-71. PubMed ID: 6132935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorazepam substitutes for the alcohol stimulus in social drinkers.
    Jackson A; Stephens DN; Duka T
    Psychopharmacology (Berl); 2003 Mar; 166(2):181-7. PubMed ID: 12529807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):776-82. PubMed ID: 6136600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative/anxiolytics.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1442-57. PubMed ID: 9316858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
    Satzger W; Engel RR; Ferguson E; Kapfhammer H; Eich FX; Hippius H
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():114-9. PubMed ID: 1974070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response to alcohol in light and moderate female social drinkers.
    Evans SM; Levin FR
    Behav Pharmacol; 2004 May; 15(3):167-81. PubMed ID: 15187575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative-stimulus effects of triazolam in light and moderate drinkers.
    Rush CR; Kelly TH; Fillmore MT; Hays LR
    Alcohol Clin Exp Res; 2003 Apr; 27(4):638-46. PubMed ID: 12711926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between effects of caffeine and lorazepam in performance tests and self-ratings.
    File SE; Bond AJ; Lister RG
    J Clin Psychopharmacol; 1982 Apr; 2(2):102-6. PubMed ID: 6122694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discriminative stimulus properties of phenazepam and lorazepam: specificity and role of GABA A receptors].
    Kalinina TS; Voronina TA; Petrianina EV
    Eksp Klin Farmakol; 2008; 71(1):3-7. PubMed ID: 18365478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias.
    Michael GA; Bacon E; Offerlin-Meyer I
    J Psychopharmacol; 2007 Sep; 21(7):691-9. PubMed ID: 17259205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge.
    Schunck T; Mathis A; Erb G; Namer IJ; Demazières A; Luthringer R
    J Psychopharmacol; 2010 May; 24(5):701-8. PubMed ID: 19460871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
    de Haas SL; de Visser SJ; van der Post JP; Schoemaker RC; van Dyck K; Murphy MG; de Smet M; Vessey LK; Ramakrishnan R; Xue L; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Jan; 22(1):24-32. PubMed ID: 18187530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
    de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
    J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of diazepam in humans.
    Johanson CE
    J Pharmacol Exp Ther; 1991 May; 257(2):634-43. PubMed ID: 2033509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam.
    Brignell CM; Rosenthal J; Curran HV
    J Psychopharmacol; 2007 Sep; 21(7):673-83. PubMed ID: 17606475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
    de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
    J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in discriminative stimulus effects of morphine in the rat.
    Craft RM; Kalivas PW; Stratmann JA
    Behav Pharmacol; 1996 Dec; 7(8):764-778. PubMed ID: 11224471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.